P

Inventor

GAN LI

CN12 patents
⚠️ This page may combine multiple inventors who share the name “GAN LI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GAN LI

3 patents
US8420613B2Apr 16, 2013

Methods and compositions for reducing amyloid beta levels

GAN LI6 citations81
US9040521B2May 26, 2015

Methods and compositions for modulating tau levels

GAN LI3 citations60
US8388953B2Mar 5, 2013

Method of increasing cathepsin B-induced cleavage of amyloid-β peptides

GAN LI4 citations57

DAVID GLADSTONE INST

3 patents
US9347085B2May 24, 2016

Methods and compositions for reducing amyloid beta levels

DAVID GLADSTONE INST3 citations71
US8691519B2Apr 8, 2014

Methods and compositions for reducing amyloid beta levels

DAVID GLADSTONE INST4 citations71
US7951367B2May 31, 2011

Methods and compositions for reducing amyloid beta levels

DAVID GLADSTONE INST5 citations69

AGY THERAPEUTICS INC

2 patents
US6924109B2Aug 2, 2005

High-throughput transcriptome and functional validation analysis

AGY THERAPEUTICS INC12 citations79
US6841351B2Jan 11, 2005

High-throughput transcriptome and functional validation analysis

AGY THERAPEUTICS INC1 citations47

THE J DAVID GLADSTONE INST

2 patents
US9585907B2Mar 7, 2017

Methods and compositions for modulating Tau levels

THE J DAVID GLADSTONE INST3 citations71
US10004753B2Jun 26, 2018

Methods for treating tauopathy

THE J DAVID GLADSTONE INST0 citations51

ROCHE DIAGNOSTICS OPERATIONS INC

1 patent
US10877053B2Dec 29, 2020

Method of determining an analyte concentration

ROCHE DIAGNOSTICS OPERATIONS INC0 citations50

GAN YONG

1 patent
US8920835B2Dec 30, 2014

Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof

GAN YONG0 citations36